LONDON (Alliance News) - Consort Medical PLC on Wednesday said its Bespak division has won a new development contract for a new drug or device which will incorporate its ASI autoinjector.
Consort said the contract has been signed with an unnamed global generic company and said the details of the contract are confidential at present.
It said the project will be referred to at INJ650 going forward and will be in its product development pipeline.
"The award of this ASI autoinjector development contract confirms Bespak's growing presence in the significant Injectables market, following the launch of the Dr. Reddy's Sumatriptan autoinjector in February 2014," said Jonathan Glenn, chief executive of Consort.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.